ACADIA Pharmaceuticals, Inc.

( )
ACAD PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. 0.04%67.591.0%$1048.60m
BIIBBiogen, Inc. 2.71%342.011.5%$718.26m
AMGNAmgen, Inc. -0.62%222.091.3%$585.61m
ILMNIllumina, Inc. 2.59%298.923.5%$440.19m
REGNRegeneron Pharmaceuticals, Inc. -0.45%397.742.6%$385.35m
VRTXVertex Pharmaceuticals, Inc. -0.74%242.011.9%$346.26m
ALXNAlexion Pharmaceuticals, Inc. 0.00%102.562.0%$208.61m
EXASEXACT Sciences Corp. 3.61%98.1824.0%$165.42m
AAgilent Technologies, Inc. 0.20%86.011.6%$151.72m
SGENSeattle Genetics, Inc. -0.13%118.076.1%$116.25m
MRNAModerna, Inc. 0.53%19.100.0%$111.87m
INCYIncyte Corp. -0.57%78.002.5%$100.64m
XLRNAcceleron Pharma, Inc. -0.48%93.666.1%$99.78m
SRPTSarepta Therapeutics, Inc. 0.31%125.4214.6%$97.24m
BMRNBioMarin Pharmaceutical, Inc. 0.87%89.014.3%$93.97m

Company Profile

ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. It operates through development and commercialization of innovative medicines segment. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.